Compare ANNX & KRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANNX | KRNT |
|---|---|---|
| Founded | 2011 | 2002 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 726.1M | 728.7M |
| IPO Year | 2020 | 2014 |
| Metric | ANNX | KRNT |
|---|---|---|
| Price | $3.49 | $14.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 5 |
| Target Price | $17.00 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 3.4M | 256.1K |
| Earning Date | 11-09-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.48 |
| Revenue Next Year | N/A | $7.27 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.36 | $12.28 |
| 52 Week High | $7.18 | $19.78 |
| Indicator | ANNX | KRNT |
|---|---|---|
| Relative Strength Index (RSI) | 36.30 | 28.48 |
| Support Level | N/A | N/A |
| Resistance Level | $4.42 | $16.63 |
| Average True Range (ATR) | 0.28 | 0.85 |
| MACD | -0.06 | -0.28 |
| Stochastic Oscillator | 10.82 | 1.02 |
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.
Kornit Digital Ltd is a developer and provider of digital solutions for the printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software, and value-added services that enable large-scale printing of short-run complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink, and other consumables, and services, including software subscriptions. The company geographically operates in the U.S., EMEA, Asia Pacific, and other countries. It derives maximum revenue from the U.S.